Education
About Us
Working with TipRanks
Follow Us
Chordate Medical Holding AB (SE:CMH)
:CMH
Total Valuation
Chordate Medical Holding AB has a market cap or net worth of kr13.44M. The enterprise value is kr14.82M.
Market Capkr13.44M
Enterprise Valuekr14.82M
Share Statistics
Chordate Medical Holding AB has 2,699,620 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,699,620
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Chordate Medical Holding AB’s return on equity (ROE) is -2.96 and return on invested capital (ROIC) is -298.47%.
Return on Equity (ROE)-2.96
Return on Assets (ROA)-1.55
Return on Invested Capital (ROIC)-298.47%
Return on Capital Employed (ROCE)-2.98
Revenue Per Employee221.56K
Profits Per Employee-9.08M
Employee Count3
Asset Turnover0.04
Inventory Turnover-0.75
Valuation Ratios
The current PE Ratio of Chordate Medical Holding AB is ―. Chordate Medical Holding AB’s PEG ratio is 0.02.
PE Ratio―
PS Ratio13.84
PB Ratio1.00
Price to Fair Value1.00
Price to FCF-0.34
Price to Operating Cash Flow-0.53
PEG Ratio0.02
Income Statement
In the last 12 months, Chordate Medical Holding AB had revenue of 664.69K and earned -27.25M in profits. Earnings per share was -26.60.
Revenue664.69K
Gross Profit1.99M
Operating Income-27.45M
Pretax Income-27.25M
Net Income-27.25M
EBITDA-25.23M
Earnings Per Share (EPS)-26.60
Cash Flow
In the last 12 months, operating cash flow was -24.69M and capital expenditures -440.50K, giving a free cash flow of -25.13M billion.
Operating Cash Flow-24.69M
Free Cash Flow-25.13M
Free Cash Flow per Share-9.31
Dividends & Yields
Chordate Medical Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change-81.89%
50-Day Moving Average5.96
200-Day Moving Average7.37
Relative Strength Index (RSI)41.87
Average Volume (3m)5.37K
Important Dates
Chordate Medical Holding AB upcoming earnings date is Nov 21, 2025, TBA (Confirmed).
Last Earnings DateAug 29, 2025
Next Earnings DateNov 21, 2025
Ex-Dividend Date―
Financial Position
Chordate Medical Holding AB as a current ratio of 0.92, with Debt / Equity ratio of 0.00%
Current Ratio0.92
Quick Ratio0.71
Debt to Market Cap0.00
Net Debt to EBITDA0.10
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Chordate Medical Holding AB has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Chordate Medical Holding AB EV to EBITDA ratio is -0.26, with an EV/FCF ratio of -0.24.
EV to Sales10.04
EV to EBITDA-0.26
EV to Free Cash Flow-0.24
EV to Operating Cash Flow-0.27
Balance Sheet
Chordate Medical Holding AB has kr4.24M in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr4.24M billion.
Cash & Marketable Securitieskr4.24M
Total Debtkr0.00
Net Cashkr4.24M
Net Cash Per Sharekr1.57
Tangible Book Value Per Sharekr1.27
Margins
Gross margin is 81.49%, with operating margin of -4129.04%, and net profit margin of -4100.21%.
Gross Margin81.49%
Operating Margin-4129.04%
Pretax Margin-4100.21%
Net Profit Margin-4100.21%
EBITDA Margin-3795.21%
EBIT Margin-4129.04%
Analyst Forecast
The average price target for Chordate Medical Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―